Byotrol reported substantial progress for the six months to 30 September, benefiting from an underlying improvement in operating cashflow and the one-month inclusion of Medimark Scientific. Revenues increased by 54% to £1.44m, resulting in an adjusted pre-tax loss of £0.46m (vs. -£0.74m), with period-end cash of £3.55m – down £0.3m from 31 March 2018. Confirmation that Medimark should meet its earn-out targets for FY 2019 is encouraging. A shortfall in the
18 Dec 2018
Byotrol - Interims – pointing the way to sustainable profitability
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Byotrol - Interims – pointing the way to sustainable profitability
Byotrol plc (BYOT:LON) | 0.2 0 (-60.0%) | Mkt Cap: 0.68m
- Published:
18 Dec 2018 -
Author:
Mark Brewer -
Pages:
14
Byotrol reported substantial progress for the six months to 30 September, benefiting from an underlying improvement in operating cashflow and the one-month inclusion of Medimark Scientific. Revenues increased by 54% to £1.44m, resulting in an adjusted pre-tax loss of £0.46m (vs. -£0.74m), with period-end cash of £3.55m – down £0.3m from 31 March 2018. Confirmation that Medimark should meet its earn-out targets for FY 2019 is encouraging. A shortfall in the